{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T03:00:29Z","timestamp":1783825229533,"version":"3.55.0"},"reference-count":22,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.3892\/ijo.2014.2599","type":"journal-article","created":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T13:21:01Z","timestamp":1408022461000},"page":"2051-2057","source":"Crossref","is-referenced-by-count":19,"title":["Activated cytotoxic T-lymphocyte immunotherapy is effective for advanced oral and maxillofacial cancers"],"prefix":"10.3892","volume":"45","author":[{"given":"TOMOKO","family":"OHTANI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YOICHI","family":"YAMADA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AKIFUMI","family":"FURUHASHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUKINOBU","family":"OHMURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SAYAKA","family":"NAKAMURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIDEFUMI","family":"KATO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KAZUHIRO","family":"YOSHIKAWA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YOSHIAKI","family":"KAZAOKA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2014,8,14]]},"reference":[{"key":"key20180107181720_b1-ijo-45-05-2051","doi-asserted-by":"crossref","DOI":"10.30875\/b469a751-en","volume-title":"The World Health Report 2004: Changing history","author":"World Health Organization","year":"2004"},{"key":"key20180107181720_b2-ijo-45-05-2051","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMra1204479","article-title":"Two hundred years of cancer research","volume":"366","author":"DeVita","year":"2012","journal-title":"N Engl J Med"},{"key":"key20180107181720_b3-ijo-45-05-2051","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1200\/JCO.2005.05.3348","article-title":"Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck","volume":"10","author":"Colevas","year":"2006","journal-title":"J Clin Oncol"},{"key":"key20180107181720_b4-ijo-45-05-2051","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM198512053132327","article-title":"Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer","volume":"313","author":"Rosenberg","year":"1985","journal-title":"N Engl J Med"},{"key":"key20180107181720_b5-ijo-45-05-2051","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/jnci\/80.3.177","article-title":"Increased vascular permeability in organs mediated by the systemic administration of lymphokine-activated killer cells and recombinant interleukin-2 in mice","volume":"80","author":"Ettinghausen","year":"1988","journal-title":"J Natl Cancer Inst"},{"key":"key20180107181720_b6-ijo-45-05-2051","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/(SICI)1096-9098(199912)72:4<211::AID-JSO6>3.0.CO;2-A","article-title":"Adoptive immunotherapy for advanced cancer patients using in vitro activated cytotoxic T lymphocytes","volume":"72","author":"Soda","year":"1999","journal-title":"J Surg Oncol"},{"key":"key20180107181720_b7-ijo-45-05-2051","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/1097-0142(19940815)74:4<1275::AID-CNCR2820740416>3.0.CO;2-Q","article-title":"Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer","volume":"74","author":"Baxevanis","year":"1994","journal-title":"Cancer"},{"key":"key20180107181720_b8-ijo-45-05-2051","first-page":"39","article-title":"T cell responses to human malignant tumors","volume":"13","author":"Knuth","year":"1992","journal-title":"Cancer Surv"},{"key":"key20180107181720_b9-ijo-45-05-2051","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jim.2004.01.001","article-title":"The interferon gamma secretion assay: a reliable tool to study interferon gamma production at the single cell level","volume":"286","author":"Desombere","year":"2004","journal-title":"J Immunol Methods"},{"key":"key20180107181720_b10-ijo-45-05-2051","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1182\/blood-2004-07-2975","article-title":"Treatment of nasopharyngeal carcinoma with Epstein-Barr virus-specific T lymphocytes","volume":"105","author":"Straathof","year":"2005","journal-title":"Blood"},{"key":"key20180107181720_b11-ijo-45-05-2051","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3324\/haematol.10433","article-title":"Phase I\/II feasibility study evaluating the generation of leukemia-reactive cytotoxic T lymphocyte lines for treatment of patients with relapsed leukemia after allogeneic stem cell transplantation","volume":"92","author":"Marijt","year":"2007","journal-title":"Haematologica"},{"key":"key20180107181720_b12-ijo-45-05-2051","first-page":"4663","article-title":"Locoregional cellular immunotherapy for patients with advanced esophageal cancer","volume":"6","author":"Toh","year":"2000","journal-title":"Clin Cancer Res"},{"key":"key20180107181720_b13-ijo-45-05-2051","doi-asserted-by":"crossref","first-page":"16168","DOI":"10.1073\/pnas.242600099","article-title":"Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells","volume":"99","author":"Yee","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107181720_b14-ijo-45-05-2051","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fphar.2012.00149","article-title":"Recurrent oral cancer: current and emerging therapeutic approaches","volume":"3","author":"da Silva","year":"2012","journal-title":"Front Pharmacol"},{"key":"key20180107181720_b15-ijo-45-05-2051","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1073\/pnas.91.9.3515","article-title":"Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor","volume":"91","author":"Kawakami","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107181720_b16-ijo-45-05-2051","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1349-7006.1997.tb00380.x","article-title":"Induction of specific cytotoxic T lymphocytes against autologous brain tumor by crossreactive allo-tumor cell stimulation","volume":"88","author":"Saitoh","year":"1997","journal-title":"Jpn J Cancer Res"},{"key":"key20180107181720_b17-ijo-45-05-2051","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nri3191","article-title":"Adoptive immunotherapy for cancer: harnessing the T cell response","volume":"22","author":"Restifo","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"key20180107181720_b18-ijo-45-05-2051","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.3489291","article-title":"A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes","volume":"233","author":"Rosenberg","year":"1986","journal-title":"Science"},{"key":"key20180107181720_b19-ijo-45-05-2051","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-11-0116","article-title":"Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy","volume":"17","author":"Rosenberg","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20180107181720_b20-ijo-45-05-2051","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00262-007-0340-1","article-title":"Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma","volume":"56","author":"Khammari","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"key20180107181720_b21-ijo-45-05-2051","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/(SICI)1097-0142(19960715)78:2<244::AID-CNCR9>3.0.CO;2-L","article-title":"A randomized trial of adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 versus standard therapy in the postoperative treatment of resected nonsmall cell lung carcinoma","volume":"78","author":"Ratto","year":"1996","journal-title":"Cancer"},{"key":"key20180107181720_b22-ijo-45-05-2051","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/hed.21298","article-title":"Second salvage surgery for re-recurrent oral cavity and oropharynx carcinoma","volume":"32","author":"Agra","year":"2010","journal-title":"Head Neck"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2014.2599\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T22:30:53Z","timestamp":1565735453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2014.2599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,14]]},"references-count":22,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,8,14]]},"published-print":{"date-parts":[[2014,11]]}},"alternative-id":["10.3892\/ijo.2014.2599"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2014.2599","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,14]]}}}